CRIS vs LXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

CRIS

53.9
AI Score
VS
CRIS Wins

LXRX

45.8
AI Score

Investment Advisor Scores

CRIS

54score
Recommendation
HOLD

LXRX

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS LXRX Winner
Net Income -32.78M -25.30M LXRX
Operating Income -21.46M -25.68M CRIS
ROE -698.2% -20.6% LXRX
ROA -172.8% -8.5% LXRX
Total Assets 18.97M 297.67M LXRX
Cash 5.07M 62.89M LXRX
Current Ratio 0.49 2.22 LXRX

Relative Price Performance (Last 90 Days)

CRIS 1M: -56.1% · 3M: -91.8% LXRX 1M: -23.7% · 3M: -36.3%

Current Technical Phase

CRIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -58.2%), weak momentum, RSI 11

RSI (14): 11.2 · Price: $0.39

LXRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.0%), weak momentum, RSI 25

RSI (14): 25.2 · Price: $1.42

Fundamentals Snapshot

Metric CRIS LXRX
Market Cap — —
Forward P/E -0.1 -7.5
Trailing P/E 0.3 —
Revenue (TTM) — —
Revenue Growth -0.7% -1.0%
Gross Margin -4.9% 0.9%
Operating Margin -8.3% -38.4%
EPS 1.32 -0.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRIS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.